MCCARTHY SEAN A. (President and CEO) received a stock award from CYTOMX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/4/2026ACC: 0001610717-26-000039
DirectorOfficer· President and CEO
Since Jul 2018
+1.19M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.19M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+210K
Price / share
—
Trade value
—
% of position
21.3%
2/2/2026
987.89K→1.20M
Total
Net shares
+210K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +210K | — | — | 21.3% | 987.89K | 1.20M |
| Total | +210K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
980K shares
Shares
+980K
Strike price
6.09
Held after
980K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock980K shares | 2/2/2026 | A · Award | +980K | 6.09 | — | 980K |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned93.16K
Total
93.16K indirect93.16K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 93.16K | Indirect |
| Total | 93.16K | 93.16K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported